248 related articles for article (PubMed ID: 36229560)
21. Development and Dynamic Regulation of Mitochondrial Network in Human Midbrain Dopaminergic Neurons Differentiated from iPSCs.
Fang D; Qing Y; Yan S; Chen D; Yan SS
Stem Cell Reports; 2016 Oct; 7(4):678-692. PubMed ID: 27666790
[TBL] [Abstract][Full Text] [Related]
22. Current State-of-the-Art and Unresolved Problems in Using Human Induced Pluripotent Stem Cell-Derived Dopamine Neurons for Parkinson's Disease Drug Development.
Antonov SA; Novosadova EV
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33806103
[TBL] [Abstract][Full Text] [Related]
23. Cryopreservation of Induced Pluripotent Stem Cell-Derived Dopaminergic Neurospheres for Clinical Application.
Hiramatsu S; Morizane A; Kikuchi T; Doi D; Yoshida K; Takahashi J
J Parkinsons Dis; 2022; 12(3):871-884. PubMed ID: 34958047
[TBL] [Abstract][Full Text] [Related]
24. Parkin and PINK1 Patient iPSC-Derived Midbrain Dopamine Neurons Exhibit Mitochondrial Dysfunction and α-Synuclein Accumulation.
Chung SY; Kishinevsky S; Mazzulli JR; Graziotto J; Mrejeru A; Mosharov EV; Puspita L; Valiulahi P; Sulzer D; Milner TA; Taldone T; Krainc D; Studer L; Shim JW
Stem Cell Reports; 2016 Oct; 7(4):664-677. PubMed ID: 27641647
[TBL] [Abstract][Full Text] [Related]
25. Parkin controls dopamine utilization in human midbrain dopaminergic neurons derived from induced pluripotent stem cells.
Jiang H; Ren Y; Yuen EY; Zhong P; Ghaedi M; Hu Z; Azabdaftari G; Nakaso K; Yan Z; Feng J
Nat Commun; 2012 Feb; 3():668. PubMed ID: 22314364
[TBL] [Abstract][Full Text] [Related]
26. Generation of functional dopaminergic neurons from human spermatogonial stem cells to rescue parkinsonian phenotypes.
Yang H; Hao D; Liu C; Huang D; Chen B; Fan H; Liu C; Zhang L; Zhang Q; An J; Zhao J
Stem Cell Res Ther; 2019 Jun; 10(1):195. PubMed ID: 31248447
[TBL] [Abstract][Full Text] [Related]
27. Single-cell transcriptomics identifies perturbed molecular pathways in midbrain organoids using α-synuclein triplication Parkinson's disease patient-derived iPSCs.
Patikas N; Ansari R; Metzakopian E
Neurosci Res; 2023 Oct; 195():13-28. PubMed ID: 37271312
[TBL] [Abstract][Full Text] [Related]
28. Rapid Conversion of Human Induced Pluripotent Stem Cells into Dopaminergic Neurons by Inducible Expression of Two Transcription Factors.
Nishimura K; Nitta T; Doi K; Takata K
Stem Cells Dev; 2022 Jun; 31(11-12):269-277. PubMed ID: 35420042
[TBL] [Abstract][Full Text] [Related]
29. A monolayer hiPSC culture system for autophagy/mitophagy studies in human dopaminergic neurons.
Stathakos P; Jiménez-Moreno N; Crompton LA; Nistor PA; Badger JL; Barbuti PA; Kerrigan TL; Randall AD; Caldwell MA; Lane JD
Autophagy; 2021 Apr; 17(4):855-871. PubMed ID: 32286126
[TBL] [Abstract][Full Text] [Related]
30. Midbrain Dopaminergic Neurons Differentiated from Human-Induced Pluripotent Stem Cells.
Tofoli FA; Semeano ATS; Oliveira-Giacomelli Á; Gonçalves MCB; Ferrari MFR; Veiga Pereira L; Ulrich H
Methods Mol Biol; 2019; 1919():97-118. PubMed ID: 30656624
[TBL] [Abstract][Full Text] [Related]
31. [Directed differentiation of human induced pluripotent stem cells into midbrain].
Xu J; Li Y; Zhong G; Fang Z; Liu C; Ma C; Wang C; Guo Y; Liu C
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Feb; 43(2):175-182. PubMed ID: 36946035
[TBL] [Abstract][Full Text] [Related]
32. Expression of early developmental markers predicts the efficiency of embryonic stem cell differentiation into midbrain dopaminergic neurons.
Salti A; Nat R; Neto S; Puschban Z; Wenning G; Dechant G
Stem Cells Dev; 2013 Feb; 22(3):397-411. PubMed ID: 22889265
[TBL] [Abstract][Full Text] [Related]
33. Activation of β-Glucocerebrosidase Reduces Pathological α-Synuclein and Restores Lysosomal Function in Parkinson's Patient Midbrain Neurons.
Mazzulli JR; Zunke F; Tsunemi T; Toker NJ; Jeon S; Burbulla LF; Patnaik S; Sidransky E; Marugan JJ; Sue CM; Krainc D
J Neurosci; 2016 Jul; 36(29):7693-706. PubMed ID: 27445146
[TBL] [Abstract][Full Text] [Related]
34. Generation of Naivetropic Induced Pluripotent Stem Cells from Parkinson's Disease Patients for High-Efficiency Genetic Manipulation and Disease Modeling.
Hu Z; Pu J; Jiang H; Zhong P; Qiu J; Li F; Wang X; Zhang B; Yan Z; Feng J
Stem Cells Dev; 2015 Nov; 24(21):2591-604. PubMed ID: 26218671
[TBL] [Abstract][Full Text] [Related]
35. Immature mDA neurons ameliorate motor deficits in a 6-OHDA Parkinson's disease mouse model and are functional after cryopreservation.
Leitner D; Ramamoorthy M; Dejosez M; Zwaka TP
Stem Cell Res; 2019 Dec; 41():101617. PubMed ID: 31731178
[TBL] [Abstract][Full Text] [Related]
36. Generation of Human Ventral Midbrain Organoids Derived from Pluripotent Stem Cells.
Sozzi E; Nilsson F; Kajtez J; Parmar M; Fiorenzano A
Curr Protoc; 2022 Sep; 2(9):e555. PubMed ID: 36121202
[TBL] [Abstract][Full Text] [Related]
37. Alpha-synuclein dynamics in induced pluripotent stem cell-derived dopaminergic neurons from a Parkinson's disease patient (PARK4) with SNCA triplication.
Fukusumi H; Togo K; Sumida M; Nakamori M; Obika S; Baba K; Shofuda T; Ito D; Okano H; Mochizuki H; Kanemura Y
FEBS Open Bio; 2021 Feb; 11(2):354-366. PubMed ID: 33301617
[TBL] [Abstract][Full Text] [Related]
38. Neuroprotective effects of erythropoietin on 6-hydroxydopamine-treated ventral mesencephalic dopamine-rich cultures.
Ganser C; Papazoglou A; Just L; Nikkhah G
Exp Cell Res; 2010 Mar; 316(5):737-46. PubMed ID: 20060824
[TBL] [Abstract][Full Text] [Related]
39. Generation of human A9 dopaminergic pacemakers from induced pluripotent stem cells.
Li H; Jiang H; Li H; Li L; Yan Z; Feng J
Mol Psychiatry; 2022 Nov; 27(11):4407-4418. PubMed ID: 35610351
[TBL] [Abstract][Full Text] [Related]
40. Development and Differentiation of Midbrain Dopaminergic Neuron: From Bench to Bedside.
Wang M; Ling KH; Tan JJ; Lu CB
Cells; 2020 Jun; 9(6):. PubMed ID: 32570916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
